Cognition Therapeutics, Inc. (CGTX) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Price / Book | 2.88 |
| FCF Yield | -9.1% |
| Sector P/E (Healthcare) | 21.7 |
CGTX overview · CGTX earnings · CGTX KPIs · CGTX investor relations · CGTX ownership · CGTX peers · CGTX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.